Neogen (NEOG) Cash & Equivalents (2016 - 2026)
Neogen has reported Cash & Equivalents over the past 17 years, most recently at $159.9 million for Q1 2026.
- For Q1 2026, Cash & Equivalents rose 25.21% year-over-year to $159.9 million; the TTM value through Feb 2026 reached $159.9 million, up 25.21%, while the annual FY2025 figure was $129.0 million, 24.39% down from the prior year.
- Cash & Equivalents for Q1 2026 was $159.9 million at Neogen, up from $145.3 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $205.8 million in Q4 2023 and troughed at $42.9 million in Q1 2022.
- A 5-year average of $129.6 million and a median of $138.9 million in 2025 define the central range for Cash & Equivalents.
- Biggest five-year swings in Cash & Equivalents: tumbled 41.65% in 2022 and later skyrocketed 267.05% in 2023.
- Year by year, Cash & Equivalents stood at $100.0 million in 2022, then surged by 105.76% to $205.8 million in 2023, then crashed by 31.85% to $140.2 million in 2024, then increased by 3.64% to $145.3 million in 2025, then rose by 10.02% to $159.9 million in 2026.
- Business Quant data shows Cash & Equivalents for NEOG at $159.9 million in Q1 2026, $145.3 million in Q4 2025, and $138.9 million in Q3 2025.